
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Optimised modular anti‐FLAG CAR T cells for solid tumor therapy - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="AE53336D8AF27BF305336D0005E2A949.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="cti">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12370372/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Clinical &amp; Translational Immunology">
<meta name="citation_title" content="Optimised modular anti‐FLAG CAR T cells for solid tumor therapy">
<meta name="citation_author" content="Xiaomeng Zhang">
<meta name="citation_author_institution" content="Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia">
<meta name="citation_author_institution" content="Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia">
<meta name="citation_author" content="Rachel Xu">
<meta name="citation_author_institution" content="Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia">
<meta name="citation_author_institution" content="Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia">
<meta name="citation_author" content="Dmitry Zorin">
<meta name="citation_author_institution" content="Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia">
<meta name="citation_author" content="Evan G Pappas">
<meta name="citation_author_institution" content="Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia">
<meta name="citation_author_institution" content="Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia">
<meta name="citation_author" content="Jiawei Tang">
<meta name="citation_author_institution" content="Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia">
<meta name="citation_author" content="Yuchen Bai">
<meta name="citation_author_institution" content="Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia">
<meta name="citation_author_institution" content="Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia">
<meta name="citation_author" content="Vicky M Qin">
<meta name="citation_author_institution" content="Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia">
<meta name="citation_author_institution" content="Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia">
<meta name="citation_author" content="Bianca von Scheidt">
<meta name="citation_author_institution" content="Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia">
<meta name="citation_author" content="Ruihong Huang">
<meta name="citation_author_institution" content="Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia">
<meta name="citation_author_institution" content="Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia">
<meta name="citation_author" content="Weronika Kulakowska">
<meta name="citation_author_institution" content="Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia">
<meta name="citation_author_institution" content="Prostate Cancer Research Group, Cancer Program, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia">
<meta name="citation_author" content="Charbel Darido">
<meta name="citation_author_institution" content="Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia">
<meta name="citation_author_institution" content="Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia">
<meta name="citation_author" content="Phillip K Darcy">
<meta name="citation_author_institution" content="Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia">
<meta name="citation_author_institution" content="Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia">
<meta name="citation_author" content="Michael H Kershaw">
<meta name="citation_author_institution" content="Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia">
<meta name="citation_author_institution" content="Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia">
<meta name="citation_author" content="Clare Y Slaney">
<meta name="citation_author_institution" content="Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia">
<meta name="citation_author_institution" content="Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia">
<meta name="citation_publication_date" content="2025 Aug 21">
<meta name="citation_volume" content="14">
<meta name="citation_issue" content="8">
<meta name="citation_firstpage" content="e70046">
<meta name="citation_doi" content="10.1002/cti2.70046">
<meta name="citation_pmid" content="40851786">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12370372/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12370372/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12370372/pdf/CTI2-14-e70046.pdf">
<meta name="description" content="Chimeric antigen receptor (CAR) T cell therapies have transformed the treatment of B cell malignancies and show promise in other diseases, including autoimmune disorders and cardiac injury. However, broader application, particularly in solid ...">
<meta name="og:title" content="Optimised modular anti‐FLAG CAR T cells for solid tumor therapy">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Chimeric antigen receptor (CAR) T cell therapies have transformed the treatment of B cell malignancies and show promise in other diseases, including autoimmune disorders and cardiac injury. However, broader application, particularly in solid ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12370372/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12370372">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1002/cti2.70046"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/CTI2-14-e70046.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12370372%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12370372/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12370372/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12370372/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-cti.jpg" alt="Clinical &amp; Translational Immunology logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Clinical &amp; Translational Immunology" title="Link to Clinical &amp; Translational Immunology" shape="default" href="http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)2050-0068" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Clin Transl Immunology</button></div>. 2025 Aug 21;14(8):e70046. doi: <a href="https://doi.org/10.1002/cti2.70046" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1002/cti2.70046</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Clin%20Transl%20Immunology%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Clin%20Transl%20Immunology%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Clin%20Transl%20Immunology%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Clin%20Transl%20Immunology%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Optimised modular anti‐FLAG CAR T cells for solid tumor therapy</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20X%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Xiaomeng Zhang</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Xiaomeng Zhang</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia</div>
<div class="p">
<sup>
<sup>2</sup>
</sup>Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20X%22%5BAuthor%5D" class="usa-link"><span class="name western">Xiaomeng Zhang</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Xu%20R%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Rachel Xu</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Rachel Xu</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia</div>
<div class="p">
<sup>
<sup>2</sup>
</sup>Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Xu%20R%22%5BAuthor%5D" class="usa-link"><span class="name western">Rachel Xu</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zorin%20D%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Dmitry Zorin</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Dmitry Zorin</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zorin%20D%22%5BAuthor%5D" class="usa-link"><span class="name western">Dmitry Zorin</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Pappas%20EG%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Evan G Pappas</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Evan G Pappas</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia</div>
<div class="p">
<sup>
<sup>2</sup>
</sup>Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Pappas%20EG%22%5BAuthor%5D" class="usa-link"><span class="name western">Evan G Pappas</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tang%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Jiawei Tang</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Jiawei Tang</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tang%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jiawei Tang</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bai%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Yuchen Bai</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Yuchen Bai</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia</div>
<div class="p">
<sup>
<sup>2</sup>
</sup>Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bai%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yuchen Bai</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Qin%20VM%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Vicky M Qin</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Vicky M Qin</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia</div>
<div class="p">
<sup>
<sup>2</sup>
</sup>Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Qin%20VM%22%5BAuthor%5D" class="usa-link"><span class="name western">Vicky M Qin</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22von%20Scheidt%20B%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Bianca von Scheidt</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Bianca von Scheidt</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22von%20Scheidt%20B%22%5BAuthor%5D" class="usa-link"><span class="name western">Bianca von Scheidt</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Huang%20R%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Ruihong Huang</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Ruihong Huang</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia</div>
<div class="p">
<sup>
<sup>2</sup>
</sup>Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Huang%20R%22%5BAuthor%5D" class="usa-link"><span class="name western">Ruihong Huang</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kulakowska%20W%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Weronika Kulakowska</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Weronika Kulakowska</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia</div>
<div class="p">
<sup>
<sup>3</sup>
</sup>Prostate Cancer Research Group, Cancer Program, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kulakowska%20W%22%5BAuthor%5D" class="usa-link"><span class="name western">Weronika Kulakowska</span></a>
</div>
</div>
<sup>1,</sup><sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Darido%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Charbel Darido</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">Charbel Darido</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia</div>
<div class="p">
<sup>
<sup>2</sup>
</sup>Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Darido%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Charbel Darido</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Darcy%20PK%22%5BAuthor%5D" class="usa-link" aria-describedby="id12"><span class="name western">Phillip K Darcy</span></a><div hidden="hidden" id="id12">
<h3><span class="name western">Phillip K Darcy</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia</div>
<div class="p">
<sup>
<sup>2</sup>
</sup>Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Darcy%20PK%22%5BAuthor%5D" class="usa-link"><span class="name western">Phillip K Darcy</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kershaw%20MH%22%5BAuthor%5D" class="usa-link" aria-describedby="id13"><span class="name western">Michael H Kershaw</span></a><div hidden="hidden" id="id13">
<h3><span class="name western">Michael H Kershaw</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia</div>
<div class="p">
<sup>
<sup>2</sup>
</sup>Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kershaw%20MH%22%5BAuthor%5D" class="usa-link"><span class="name western">Michael H Kershaw</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Slaney%20CY%22%5BAuthor%5D" class="usa-link" aria-describedby="id14"><span class="name western">Clare Y Slaney</span></a><div hidden="hidden" id="id14">
<h3><span class="name western">Clare Y Slaney</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia</div>
<div class="p">
<sup>
<sup>2</sup>
</sup>Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Slaney%20CY%22%5BAuthor%5D" class="usa-link"><span class="name western">Clare Y Slaney</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="cti270046-aff-0001">
<sup>
<sup>1</sup>
</sup>Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia</div>
<div id="cti270046-aff-0002">
<sup>
<sup>2</sup>
</sup>Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia</div>
<div id="cti270046-aff-0003">
<sup>
<sup>3</sup>
</sup>Prostate Cancer Research Group, Cancer Program, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia</div>
<div class="author-notes p">
<div class="fn" id="correspondenceTo">
<sup>*</sup><p class="display-inline">

<strong>Correspondence</strong>
, 
Clare Y Slaney, Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. 
E‐mail: <span>clare.slaney@petermac.org</span>

</p>
</div>
<div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Revised 2025 Jun 15; Received 2025 Mar 26; Accepted 2025 Jun 27; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2025 The Author(s). <em>Clinical &amp; Translational Immunology</em> published by John Wiley &amp; Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology, Inc.</div>
<p>This is an open access article under the terms of the <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by/4.0/</a> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12370372  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40851786/" class="usa-link">40851786</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<section id="cti270046-sec-0101"><h3 class="pmc_sec_title">Objectives</h3>
<p>Chimeric antigen receptor (CAR) T cell therapies have transformed the treatment of B cell malignancies and show promise in other diseases, including autoimmune disorders and cardiac injury. However, broader application, particularly in solid tumours, is limited by challenges such as antigen escape and tumour heterogeneity. This study aimed to develop an anti‐FLAG CAR capable of engaging FLAG‐tagged secondary reagents, providing a flexible and adaptable targeting strategy.</p></section><section id="cti270046-sec-0102"><h3 class="pmc_sec_title">Methods</h3>
<p>We engineered a humanised anti‐FLAG CAR to engage FLAG‐tagged secondary reagents. The initial construct exhibited tonic signalling, which was addressed through structural optimisation. Therapeutic efficacy was assessed in solid tumour mouse models expressing either FLAG or a FLAG‐tagged secondary targeting reagent.</p></section><section id="cti270046-sec-0103"><h3 class="pmc_sec_title">Results</h3>
<p>The initial anti‐FLAG CAR showed functional activity but exhibited tonic signalling and exhaustion, limiting its therapeutic utility. Structural optimisation significantly reduced exhaustion and improved T cell persistence and functionality. The optimised CAR T cells effectively inhibited tumour growth in models using either FLAG‐ engineered tumour cells or a FLAG‐tagged secondary targeting reagent.</p></section><section id="cti270046-sec-0104"><h3 class="pmc_sec_title">Conclusion</h3>
<p>Our findings underscore the importance of CAR design in minimising exhaustion and enhancing therapeutic efficacy. This work supports a modular CAR T cell platform with the potential to overcome tumour antigen heterogeneity and immune evasion in solid cancers.</p></section><section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> chimeric antigen receptor, FLAG, HER2, solid cancers, tonic signalling</p></section></section><section class="abstract" id="abstract2"><hr class="headless">
<p>This study presents a modular anti‐FLAG CAR T‐cell system that enables flexible tumor targeting through FLAG‐tagged reagents. Structural optimisation of the CAR reduced tonic signalling and glycolytic metabolism, mitigating T‐cell exhaustion.</p>
<section class="bt xbox font-sm" id="cti270046-blkfxd-0001"><p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d7e/12370372/4f9b28d69ade/CTI2-14-e70046-g002.jpg" loading="lazy" id="jats-graphic-1" height="329" width="332" alt="graphic file with name CTI2-14-e70046-g002.jpg"></p></section></section><section id="cti270046-sec-0001"><h2 class="pmc_sec_title">Introduction</h2>
<p>Chimeric antigen receptor (CAR) T‐cell therapies have revolutionised the treatment of B‐cell haematological cancers and are regarded as one of the most potent advancements in cancer treatment.<a href="#cti270046-bib-0001" class="usa-link" aria-describedby="cti270046-bib-0001">
<sup>1</sup>
</a>, <a href="#cti270046-bib-0002" class="usa-link" aria-describedby="cti270046-bib-0002">
<sup>2</sup>
</a> In recent years, CAR T cells have also demonstrated potential in other diseases, such as autoimmune diseases,<a href="#cti270046-bib-0003" class="usa-link" aria-describedby="cti270046-bib-0003">
<sup>3</sup>
</a> infectious diseases<a href="#cti270046-bib-0004" class="usa-link" aria-describedby="cti270046-bib-0004">
<sup>4</sup>
</a> and cardiac injury,<a href="#cti270046-bib-0005" class="usa-link" aria-describedby="cti270046-bib-0005">
<sup>5</sup>
</a> underscoring their broad therapeutic applications.</p>
<p>However, the therapeutic efficacy of CAR T cells in cancer treatment remains inconsistent across cancer types and a significant proportion of patients either exhibit primary resistance or experience disease relapse because of antigen escape—a mechanism whereby cancer cells downregulate or entirely lose target antigen expression.<a href="#cti270046-bib-0006" class="usa-link" aria-describedby="cti270046-bib-0006">
<sup>6</sup>
</a> Compelling evidence suggests that these antigen‐escape patterns are equally pervasive in solid tumors.<a href="#cti270046-bib-0007" class="usa-link" aria-describedby="cti270046-bib-0007">
<sup>7</sup>
</a> Antigen heterogeneity, the diverse and variable expression of tumor antigens, further exacerbates therapeutic challenges.<a href="#cti270046-bib-0002" class="usa-link" aria-describedby="cti270046-bib-0002">
<sup>2</sup>
</a>, <a href="#cti270046-bib-0007" class="usa-link" aria-describedby="cti270046-bib-0007">
<sup>7</sup>
</a>
</p>
<p>There is a critical need for CAR T‐cell strategies that enable flexible targeting of diverse antigens. This adaptability is essential to address tumor heterogeneity and prevent antigen escape. In this study, we designed a novel humanised anti‐FLAG CAR to function in combination with FLAG‐tagged secondary reagents that specifically bind tumor‐associated antigens. Although the initial anti‐FLAG CAR demonstrated functional activity, <em>in vitro</em> culture revealed premature T‐cell exhaustion critically limiting its translational potential. To tackle this challenge, we implemented a structural redesign of the CAR architecture that mitigated tonic signalling, restored physiological signalling and rebalanced metabolic flux towards oxidative phosphorylation. The engineered anti‐FLAG CAR T cells demonstrated robust expansion, exhibited potent antigen‐specific cytotoxicity and secreted elevated IFN‐γ when co‐cultured with target cancer cells.</p>
<p>In NSG mice bearing orthotopic FLAG‐expressing MDA‐MB‐468 breast tumors, the optimised anti‐FLAG CAR T cells achieved complete tumor eradication. These CAR T cells also demonstrated potent efficacy when used in combination with a tumor‐targeting protein bearing a FLAG‐tag for CAR engagement. This modular approach offers a promising strategy for flexible targeting of diverse antigens by using FLAG‐tagged antibodies to bridge anti‐FLAG CAR T cells to tumor cells, with the FLAG epitope serving as a universal docking site to allow rapid antigen switching.</p></section><section id="cti270046-sec-0002"><h2 class="pmc_sec_title">Results</h2>
<p>Here, we developed an anti‐FLAG CAR (referred to as FLAG‐CAR) using a humanised murine single‐chain variable fragment (scFv) sequence<a href="#cti270046-bib-0008" class="usa-link" aria-describedby="cti270046-bib-0008">
<sup>8</sup>
</a> (Figure <a href="#cti270046-fig-0001" class="usa-link">1a</a>). This second‐generation CAR incorporates a human CD28 costimulatory domain and a CD3ζ—chain intracellular signalling domain, connected to the scFv via a human CD8 hinge. To enable visualisation, the construct includes a MYC‐tag and a GFP reporter. The entire construct is driven by a human eukaryotic translation elongation factor 1 alpha (EF‐1α) promoter. As an experimental control, we used an anti‐HER2 CAR (HER2‐CAR) with an identical design, differing only in the scFv, which specifically targets the human HER2 antigen. The selection of HER2‐CAR as a control is because of the fact that HER2‐CAR is clinically validated with a proven safety profile in human trials,<a href="#cti270046-bib-0009" class="usa-link" aria-describedby="cti270046-bib-0009">
<sup>9</sup>
</a>, <a href="#cti270046-bib-0010" class="usa-link" aria-describedby="cti270046-bib-0010">
<sup>10</sup>
</a> and an experimentally optimised system with established protocols has been established in our laboratory's CAR T‐cell research pipeline.<a href="#cti270046-bib-0011" class="usa-link" aria-describedby="cti270046-bib-0011">
<sup>11</sup>
</a>, <a href="#cti270046-bib-0012" class="usa-link" aria-describedby="cti270046-bib-0012">
<sup>12</sup>
</a>, <a href="#cti270046-bib-0013" class="usa-link" aria-describedby="cti270046-bib-0013">
<sup>13</sup>
</a>
</p>
<figure class="fig xbox font-sm" id="cti270046-fig-0001"><h3 class="obj_head">Figure 1.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d7e/12370372/bbdcde6f582d/CTI2-14-e70046-g003.jpg" loading="lazy" id="jats-graphic-3" height="728" width="625" alt="Figure 1"></p>
<div class="p text-right font-secondary"><a href="figure/cti270046-fig-0001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Development of a FLAG‐CAR. <strong>(a)</strong> Diagram illustrating the vector designs for FLAG‐CAR and HER2‐CAR. <strong>(b)</strong> Representative transduction efficiency of chimeric antigen receptor (CAR) T cells and the CD4:CD8 ratio at MOI = 2. <strong>(c)</strong> Cytotoxicity of untransduced (UTD) or FLAG‐CAR T cells against luciferase‐expressing MDA‐MB‐468 (FLAG<sup>−</sup> or FLAG<sup>+</sup>) cells. Experiments were repeated independently at least three times with consistent results, each performed in triplicate. Representative data with technical replicates were shown as mean ± SEM. Statistical significance: ****<em>P</em> ≤ 0.0001.</p></figcaption></figure><p>The FLAG‐CAR lentiviral vector successfully transduced activated T cells derived from human peripheral blood mononuclear cells (PBMC), achieving a robust transduction efficiency consistently exceeding 70% at a multiplicity of infection (MOI) of 2:1 and a balanced CD4:CD8 ratio (Figure <a href="#cti270046-fig-0001" class="usa-link">1b</a>). The resulting FLAG‐CAR T cells effectively exert cytotoxicity against cancer cells in an antigen‐specific manner in standard <em>in vitro</em> cytotoxicity assays (Figure <a href="#cti270046-fig-0001" class="usa-link">1c</a>).</p>
<p>Although the FLAG‐CAR T cells exhibited overall good functionality, we consistently observed high background killing at high Effector: Target (E:T) ratios <em>in vitro</em> (Figure <a href="#cti270046-fig-0001" class="usa-link">1c</a>), and they also failed to expand effectively <em>in vitro</em>, unlike HER2‐CAR T cells (Figure <a href="#cti270046-fig-0002" class="usa-link">2a and b</a>). This limitation was not because of the MOI, as evidenced by preserved expansion kinetics across MOI ratios ranging from 5:1 to 1:1 (Supplementary figure <a href="#cti270046-supitem-0001" class="usa-link">1</a>). The FLAG‐CAR T cells also exhibited elevated exhaustion markers, including PD‐1 and LAG‐3 (Figure <a href="#cti270046-fig-0002" class="usa-link">2c</a>). In addition, FLAG‐CAR T cells demonstrated higher background cytotoxicity (Figure <a href="#cti270046-fig-0002" class="usa-link">2d</a>) and lower antigen‐specific secretion of the pro‐inflammatory cytokines IFN‐γ and TNF‐α (Figure <a href="#cti270046-fig-0002" class="usa-link">2e</a>). The lack of expansion, increased expression of exhaustion markers and decreased cytokine secretion upon activation have been frequently described as cell exhaustion and attributed to tonic signalling,<a href="#cti270046-bib-0014" class="usa-link" aria-describedby="cti270046-bib-0014">
<sup>14</sup>
</a>, <a href="#cti270046-bib-0015" class="usa-link" aria-describedby="cti270046-bib-0015">
<sup>15</sup>
</a>, <a href="#cti270046-bib-0016" class="usa-link" aria-describedby="cti270046-bib-0016">
<sup>16</sup>
</a> where the exhaustion‐like cell phenotype is induced by antigen‐independent clustering of CARs on T cells.</p>
<figure class="fig xbox font-sm" id="cti270046-fig-0002"><h3 class="obj_head">Figure 2.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d7e/12370372/38fee611c083/CTI2-14-e70046-g006.jpg" loading="lazy" id="jats-graphic-5" height="420" width="709" alt="Figure 2"></p>
<div class="p text-right font-secondary"><a href="figure/cti270046-fig-0002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>FLAG‐CAR T cells exhibit an exhausted‐like phenotype. <strong>(a)</strong> Growth curves and <strong>(b)</strong> Fold expansion of FLAG‐ and HER2‐CAR T cells over 10 days post‐transduction. <strong>(c)</strong> Percentage of PD‐1 and LAG‐3 expression of anti‐HER2 chimeric antigen receptor (CAR), anti‐FLAG CAR and UTD T cells. <strong>(d)</strong> Cytotoxic activity and <strong>(e)</strong> IFN‐γ and TNF‐α secretion by FLAG‐CAR, HER2‐CAR T cells and UTD T cells. <strong>(f)</strong> Memory phenotypes of FLAG‐CAR T cells without treatment or with the addition of dasatinib at 100 nM from Days 8–15 in culture. Experiments were performed independently at least twice with similar results, each with three to five replicates. Representative data are shown as mean ± SEM with three to five technical replicates. Statistical significance: ** <em>P</em> ≤ 0.01, **** <em>P</em> ≤ 0.0001.</p></figcaption></figure><p>To confirm the FLAG‐CAR T cells were experiencing tonic signalling, we treated the FLAG‐CAR T cells with dasatinib, a tyrosine kinase inhibitor known to rescue CAR T cells from tonic signalling.<a href="#cti270046-bib-0017" class="usa-link" aria-describedby="cti270046-bib-0017">
<sup>17</sup>
</a> Dasatinib functions by inhibiting downstream signalling pathways of T‐cell activation, thereby preventing continuous activation that can lead to dysfunction. Following incubation with dasatinib for 7 days, the phenotype of the FLAG‐CAR T cells was rescued (Figure <a href="#cti270046-fig-0002" class="usa-link">2f</a>) and cell growth restored. These findings further provide evidence that these cells undergo tonic signalling and are progressing to functional exhaustion.</p>
<p>To address the limitations of the FLAG‐CAR T‐cell functions, which were impaired by tonic signalling, we modified the CAR plasmid structure and generated new constructs, as illustrated in Figure <a href="#cti270046-fig-0003" class="usa-link">3a</a>. The original design, designated as CAR 1, served as the baseline for comparison. While the scFv region is known to play a pivotal role in altering the tonic‐signalling phenotype,<a href="#cti270046-bib-0014" class="usa-link" aria-describedby="cti270046-bib-0014">
<sup>14</sup>
</a> our options for modification were constrained by the limited availability of scFv sequences. We used a recently developed artificial intelligence (AI)‐based calculator, CAR‐Toner,<a href="#cti270046-bib-0016" class="usa-link" aria-describedby="cti270046-bib-0016">
<sup>16</sup>
</a> to assess the surface electrostatic properties of our CAR constructs by calculating the positively charged patches (PCPs) score. This score quantifies the extent of positively charged regions on the protein surface and serves as a proxy for electrostatic charge, which has been associated with CAR tonic signalling.<a href="#cti270046-bib-0014" class="usa-link" aria-describedby="cti270046-bib-0014">
<sup>14</sup>
</a> Interestingly, our FLAG‐CAR was not predicted to exhibit significantly greater tonic signalling than our HER2‐CAR (FLAG‐CAR score = 54; HER2‐CAR score = 49), suggesting that FLAG‐CAR is not predicted to exhibit significantly higher tonic signalling based on electrostatic surface charge alone. Therefore, we decided to retain the original humanised scFv sequence and implement changes in other parts of the FLAG‐CAR.</p>
<figure class="fig xbox font-sm" id="cti270046-fig-0003"><h3 class="obj_head">Figure 3.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d7e/12370372/125371e6bbd3/CTI2-14-e70046-g007.jpg" loading="lazy" id="jats-graphic-7" height="572" width="709" alt="Figure 3"></p>
<div class="p text-right font-secondary"><a href="figure/cti270046-fig-0003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Designs of new FLAG‐CARs. <strong>(a)</strong> Diagram of the new FLAG‐CAR designs. CD8αt: truncated human CD8α hinge sequence. <strong>(b)</strong> Chimeric antigen receptor (CAR) T‐cell transduction efficiency. Experiments were performed independently at least three times with consistent results. Data are represented as mean ± SEM from technical triplicates.</p></figcaption></figure><p>Notably, HER2‐CAR T cells, which did not exhibit an exhaustion‐like phenotype, utilised a VH‐VL scFv configuration, whereas the relatively exhausted FLAG‐CAR employed a VL‐VH configuration. Thus, we redesigned the FLAG‐CARs to adopt the VH‐VL configuration. In CAR 2, we modified only the scFv structure by swapping the VH and VL chains while retaining the rest of the original design.</p>
<p>The current food and drug administration (FDA)‐approved CAR T‐cell products incorporate CD8α, CD28 and IgG4 hinge domains.<a href="#cti270046-bib-0018" class="usa-link" aria-describedby="cti270046-bib-0018">
<sup>18</sup>
</a> Numerous studies have demonstrated that the hinge domain, which connects the scFv to the CAR structure and provides flexibility for antigen access on cancer cells, significantly influences CAR T‐cell performance.<a href="#cti270046-bib-0018" class="usa-link" aria-describedby="cti270046-bib-0018">
<sup>18</sup>
</a> Shorter hinge regions have been associated with improved CAR T‐cell efficacy, particularly for targeting membrane‐distal antigens.<a href="#cti270046-bib-0019" class="usa-link" aria-describedby="cti270046-bib-0019">
<sup>19</sup>
</a> To optimise the CAR design, we first modified the hinge. In our original design (CAR 1), we used a human CD8α hinge. One modification involved replacing the CD8α hinge with a human CD28 hinge, which has been reported to enhance CD19‐CAR T‐cell function (CAR 3).<a href="#cti270046-bib-0020" class="usa-link" aria-describedby="cti270046-bib-0020">
<sup>20</sup>
</a> Another approach used a truncated human CD8α hinge sequence (CD8αt), reported to reduce background non‐antigen‐related activity (CAR 4–CAR 6, Supplementary figure <a href="#cti270046-supitem-0001" class="usa-link">2</a>).<a href="#cti270046-bib-0021" class="usa-link" aria-describedby="cti270046-bib-0021">
<sup>21</sup>
</a> In CAR 5, we also replaced the cysteine (C) residue in the CD28 transmembrane (TM) domain with an alanine (A), a mutation previously reported to reduce tonic signalling.<a href="#cti270046-bib-0021" class="usa-link" aria-describedby="cti270046-bib-0021">
<sup>21</sup>
</a> Additionally, in the immunoreceptor tyrosine‐based activating motifs (ITAMs), we substituted four tyrosines (Y) in ITAMs 2 and 3 with phenylalanines (F). This approach, aimed at reducing phosphorylation and basal CAR T‐cell signalling, was shown to enhance proliferation in response to antigen stimulation and improve CAR T‐cell function <em>in vivo</em>.<a href="#cti270046-bib-0022" class="usa-link" aria-describedby="cti270046-bib-0022">
<sup>22</sup>
</a> In CAR 6, we incorporated findings from previous studies, replacing the traditional CD28 and CD3ζ domains with a ZAP70 containing the kinase domain and interdomain B (ZAP70<sup>KIDB</sup>). This design was found to significantly reduce tonic signalling by bypassing upstream CD3ζ and LCK signalling, relying solely on the kinase domain's activity to engage downstream signalling molecules.<a href="#cti270046-bib-0021" class="usa-link" aria-describedby="cti270046-bib-0021">
<sup>21</sup>
</a>
</p>
<p>All six CAR constructs were successfully packaged into lentiviral vectors, achieving transduction rates exceeding 70% at an MOI of 2:1 in human T cells (Figure <a href="#cti270046-fig-0003" class="usa-link">3b</a>). Excitingly, all the new CARs (CAR 2–CAR 6) exhibited improved phenotypes compared to the original FLAG‐CAR (CAR 1). While only ~30% of CAR1‐transduced cells displayed a T<sub>SCM</sub>‐like phenotype, &gt; 50% of cells transduced with CAR 2–CAR 5 and HER2‐CAR were T<sub>SCM</sub>‐like (Figure <a href="#cti270046-fig-0004" class="usa-link">4a</a>). The new CARs showed significantly better expansion <em>in vitro</em>. Similar to the non‐exhausted HER2‐CAR, the five new FLAG‐CARs expanded ~150–200 fold within 2 weeks. In contrast, CAR 1 failed to expand and eventually led to a collapse of the cell culture (Figures <a href="#cti270046-fig-0004" class="usa-link">4b and c</a> and <a href="#cti270046-fig-0002" class="usa-link">2a</a>). <em>In vitro</em> assays further demonstrated the superior functionality of FLAG‐CAR 3–5. These three new CAR T cells showed enhanced specific killing of FLAG<sup>+</sup> cancer cells compared to CAR 1 (Figure <a href="#cti270046-fig-0004" class="usa-link">4d</a>). Additionally, CAR 3 and CAR 4 T cells secreted significantly higher levels of IFN‐γ when co‐cultured with FLAG<sup>+</sup> cancer cells, further confirming their improved specificity and reduced exhaustion (Figure <a href="#cti270046-fig-0004" class="usa-link">4e</a>). Although CAR 2 and CAR 6 demonstrated a strong expansion rate and favorable memory phenotype <em>in vitro</em>, the new design did not improve the functionality of these two CARs. CAR 2 did not show any significantly enhanced effect on specific killing compared to CAR 1 (Figure <a href="#cti270046-fig-0004" class="usa-link">4d</a>). It maintained a high background IFN‐γ secretion level while exhibiting limited ability to secrete IFN‐γ when incubated with FLAG<sup>+</sup> cancer cells (Figure <a href="#cti270046-fig-0004" class="usa-link">4e</a>). This suggests ineffective activation coupled with off‐target activity. CAR 6 completely lacked both antigen‐specific cytotoxicity and cytokine response (Figure <a href="#cti270046-fig-0004" class="usa-link">4d and e</a>), indicating a non‐functional receptor configuration.</p>
<figure class="fig xbox font-sm" id="cti270046-fig-0004"><h3 class="obj_head">Figure 4.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d7e/12370372/0eadf74ebef1/CTI2-14-e70046-g004.jpg" loading="lazy" id="jats-graphic-9" height="608" width="709" alt="Figure 4"></p>
<div class="p text-right font-secondary"><a href="figure/cti270046-fig-0004/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Characterisation of the optimised FLAG‐CARs. <strong>(a)</strong> Phenotypic analysis of new FLAG‐CAR T cells, gated on CD3<sup>+</sup>CAR<sup>+</sup> cells. <strong>(b, c)</strong>
<em>In vitro</em> expansion of chimeric antigen receptor (CAR) T cells after CAR transduction. <strong>(d)</strong> Specific cytotoxic activity of CAR T cells against target cells. <strong>(e)</strong> IFN‐γ secretion by CAR T cells co‐incubated with MDA‐MB‐468 (FLAG<sup>−</sup> or FLAG<sup>+</sup>) cells. Experiments were carried out independently at least twice with consistent results, each with technical triplicates. Data are presented with technical triplicates shown as mean ± SEM, except for Figure <a href="#cti270046-fig-0004" class="usa-link">4d</a> (biological replicates, <em>n</em> = 3 or 4). Statistical significance: * <em>P</em> ≤ 0.05, ** <em>P</em> ≤ 0.01, *** <em>P</em> ≤ 0.001, **** <em>P</em> ≤ 0.0001.</p></figcaption></figure><p>We next evaluated the anti‐tumor effects of the most promising CARs, CAR 3–CAR 5, using a FLAG<sup>+</sup> solid tumor model. In this model, MDA‐MB‐468 human breast cancer cells were orthotopically engrafted into the mammary glands of immunocompromised NSG mice. To simulate a solid tumor setting, where a FLAG‐tagged scFv binds the tumor antigen on the tumor cell surface, the MDA‐MB‐468 cells were transduced with a non‐functional scFv containing a C‐terminal FLAG peptide and a transmembrane domain (Supplementary figure <a href="#cti270046-supitem-0001" class="usa-link">3</a>). This construct, which lacks antigen‐binding capacity, anchors the FLAG peptide to the tumor cell surface and is hereafter referred to as MDA‐MB‐468‐FLAG. Once established, the tumors were treated with FLAG‐CAR T cells. Remarkably, CAR 3–CAR 5 effectively inhibited the growth of orthotopic MDA‐MB‐468‐FLAG tumors in NSG mice, achieving complete eradication of the cancers (Figure <a href="#cti270046-fig-0005" class="usa-link">5a</a>) and extended survival (Figure <a href="#cti270046-fig-0005" class="usa-link">5b</a>). In contrast, the original CAR 1 that exhibited tonic signalling showed only a marginal effect on MDA‐MB‐468‐FLAG tumor progression (Figure <a href="#cti270046-fig-0005" class="usa-link">5a</a>). There was no overt toxicity observed in any treatment groups (Figure <a href="#cti270046-fig-0005" class="usa-link">5c</a>).</p>
<figure class="fig xbox font-sm" id="cti270046-fig-0005"><h3 class="obj_head">Figure 5.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d7e/12370372/574c9ed7bc0a/CTI2-14-e70046-g001.jpg" loading="lazy" id="jats-graphic-11" height="602" width="709" alt="Figure 5"></p>
<div class="p text-right font-secondary"><a href="figure/cti270046-fig-0005/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>
<em>In vivo</em> functional comparison of the anti‐FLAG chimeric antigen receptor (CAR) T cells. <strong>(a)</strong> MDA‐MB‐468‐FLAG tumor growth in NSG mice. After 15 days of mammary gland tumor engraftment, NSG mice received 0.5 Gy total body irradiation and treatment with 2 × 10<sup>6</sup> CAR T cells (FLAG‐CAR 4, <em>n</em> = 4; other groups, <em>n</em> = 5). <strong>(b)</strong> Survival of mice. Endpoint is defined as tumor size &gt; 100 mm<sup>2</sup>. <strong>(c)</strong> Body weight. <strong>(d)</strong> NSG mice bearing MDA‐MB‐468‐FLAG mammary gland tumors received 5 × 10<sup>6</sup> FLAG‐CAR 1 or FLAG‐CAR 4 T‐cell treatment after 28 days of tumor engraftment. Data are shown as normalised CAR T‐cell numbers in spleens and tumors, seven days after CAR T‐cell treatment (<em>n</em> = 5). <strong>(e)</strong> Phenotypes of CAR T cells in <strong>(d)</strong>. Experiments have been independently performed at least twice. Data are presented as mean ± SEM from one experiment. Statistical significance: * <em>P</em> ≤ 0.05, ** <em>P</em> ≤ 0.01, *** <em>P</em> ≤ 0.001, **** <em>P</em> ≤ 0.0001.</p></figcaption></figure><p>Among the three effective FLAG‐CARs (CAR 3, CAR 4 and CAR 5), we selected CAR 4 for further investigation because of its superior <em>in vitro</em> and <em>in vivo</em> performance. Although CAR 3 demonstrated strong <em>in vivo</em> efficacy and specific killing, it consistently exhibited high background IFN‐γ secretion (Figure <a href="#cti270046-fig-0004" class="usa-link">4e</a>). CAR 5 lacked IFN‐γ secretion upon co‐culture with target cancer cells (Figure <a href="#cti270046-fig-0004" class="usa-link">4e</a>). As shown in Supplementary figure <a href="#cti270046-supitem-0001" class="usa-link">4</a>, no significant differences were observed among FLAG‐CAR 1, FLAG‐CAR 4 and HER2‐CAR T cells in terms of transduction efficiency, CAR surface expression or CD4<sup>+</sup>/CD8<sup>+</sup> T‐cell composition across four individual donors. These results indicate that the observed functional differences between the CAR constructs are unlikely to be as a result of variability in transduction levels or T‐cell subset distribution. Considering these factors, we prioritised CAR4 for further study to understand the mechanisms underlying its superior performance and advance its development towards clinical translation.</p>
<p>Flow cytometric analysis revealed that 7 days post‐treatment, CAR 4‐treated mice had significantly more CAR T cells in both the spleens and tumors of the MDA‐MB‐468‐FLAG tumor‐bearing mice compared to CAR 1‐treated mice (Figure <a href="#cti270046-fig-0005" class="usa-link">5d</a>). In addition, CAR 4 T cells in the spleens and tumors had a higher proportion of cells with a T<sub>CM</sub>‐like phenotype (Figure <a href="#cti270046-fig-0005" class="usa-link">5e</a>), which are typically associated with superior <em>in vivo</em> efficacy, expansion and persistence.<a href="#cti270046-bib-0001" class="usa-link" aria-describedby="cti270046-bib-0001">
<sup>1</sup>
</a>, <a href="#cti270046-bib-0023" class="usa-link" aria-describedby="cti270046-bib-0023">
<sup>23</sup>
</a> In contrast, tumors from CAR 1‐treated mice contained significantly more cells with T<sub>EM</sub> and T<sub>EMRA</sub> phenotypes. These cells are considered fully differentiated, have a short lifespan and limited <em>in vivo</em> expansion capacity.<a href="#cti270046-bib-0001" class="usa-link" aria-describedby="cti270046-bib-0001">
<sup>1</sup>
</a>, <a href="#cti270046-bib-0023" class="usa-link" aria-describedby="cti270046-bib-0023">
<sup>23</sup>
</a>
</p>
<p>Confocal microscopy revealed that CAR 4 exhibited normal clustering on the T‐cell surface with a relatively even distribution, closely resembling the HER2‐CAR (Figure <a href="#cti270046-fig-0006" class="usa-link">6a and b</a>). In contrast, CAR 1 displayed a punctate phenotype, characteristic of high tonic‐signalling CARs reported in previous studies.<a href="#cti270046-bib-0014" class="usa-link" aria-describedby="cti270046-bib-0014">
<sup>14</sup>
</a>, <a href="#cti270046-bib-0015" class="usa-link" aria-describedby="cti270046-bib-0015">
<sup>15</sup>
</a>
</p>
<figure class="fig xbox font-sm" id="cti270046-fig-0006"><h3 class="obj_head">Figure 6.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d7e/12370372/14f808736c1f/CTI2-14-e70046-g008.jpg" loading="lazy" id="jats-graphic-13" height="772" width="709" alt="Figure 6"></p>
<div class="p text-right font-secondary"><a href="figure/cti270046-fig-0006/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Enhanced signalling and metabolism of the optimised CAR4. <strong>(a)</strong> Lattice Lightsheet microscopy images showing chimeric antigen receptor (CAR) (MYC), CD3 and GFP expression on CAR T cells in the absence of antigen stimulation. Scale bars, 3 μm. <strong>(b)</strong> Percentage of membrane area expressing CAR. <strong>(c)</strong> pERK signalling in CAR T cells at a resting state (basal), and after incubation with antigen‐positive (FLAG<sup>+</sup> or HER2<sup>+</sup>) or antigen‐negative (FLAG<sup>−</sup> HER2<sup>−</sup>) cancer cells at a ratio of 1:1 for 30 min. <strong>(d)</strong> Fold change in pERK mean fluorescence intensity (MFI) over 30 min of incubation with antigen‐positive cells, normalised to resting state. <strong>(e)</strong> Oxygen consumption rate (OCR) and <strong>(f)</strong> extracellular acidification rate (ECAR) curves from Seahorse assay. Oligo, oligomycin; FCCP, Carbonyl cyanide‐p‐trifluoromethoxyphenylhydrazone; rot/AA, rotenone and antimycin A. <strong>(g)</strong> Basal and spare respiratory capacity of FLAG‐CAR 1, FLAG‐CAR 4 and HER2‐CAR T cells. Experiments were performed independently at least twice with consistent results. Data are presented with technical replicates shown as mean ± SEM. Statistical significance: * <em>P</em> ≤ 0.05, ** <em>P</em> ≤ 0.01, *** <em>P</em> ≤ 0.001, **** <em>P</em> ≤ 0.0001.</p></figcaption></figure><p>Additionally, ERK phosphorylation, a marker of MAPK‐driven tonic signalling,<a href="#cti270046-bib-0014" class="usa-link" aria-describedby="cti270046-bib-0014">
<sup>14</sup>
</a> is significantly lower in CAR 4 cells than in CAR 1, indicating reduced tonic signalling in CAR 4 (Figure <a href="#cti270046-fig-0006" class="usa-link">6c</a>). Upon antigen stimulation, CAR 4 cells exhibit approximately 3.5‐fold higher pERK expression than CAR 1 cells, suggesting enhanced antigen‐specific activation. Notably, this activation was even greater than that observed in HER2‐CAR cells (Figure <a href="#cti270046-fig-0006" class="usa-link">6d</a>). This pattern suggests that CAR 4 maintains a lower basal activation state, while retaining the capacity for robust ERK activation upon stimulation. Given the role of the MAPK pathway in metabolic regulation, this dynamic ERK response may contribute to enhanced mitochondrial function, supporting a metabolically fitter phenotype in CAR 4 compared to CAR 1 T cells.</p>
<p>We subsequently performed a Seahorse assay to compare the metabolism of CAR 4 and CAR 1, using HER2‐CAR as the experimental control. As HER2‐CAR differs from FLAG‐CARs in multiple domains, including scFv and hinge, it was used solely as a positive control rather than for direct comparison. Interestingly, the results revealed that the HER2‐CAR differs significantly from the FLAG‐CARs, exhibiting lower basal and maximal respiration rates, as well as a distinct extracellular acidification rate (ECAR) (Figure <a href="#cti270046-fig-0006" class="usa-link">6e and f</a>), highlighting the fundamental differences between HER2‐CAR and FLAG‐CAR T cells. Between FLAG‐CARs, CAR 4 outperformed CAR 1, demonstrating higher oxidative phosphorylation (OXPHOS) reflecting a higher mitochondrial respiration, as reflected by an increased basal oxygen consumption rate (OCR) and a higher spare respiratory capacity (SRC) (Figure <a href="#cti270046-fig-0006" class="usa-link">6g</a>). Additionally, CAR 4 showed reduced glycolysis, as indicated by a lower ECAR. The reduced ECAR and enhanced OXPHOS indicate that CAR 4 T cells have a shift towards mitochondrial respiration for oxidative metabolism and rely less on glycolysis for energy production.<a href="#cti270046-bib-0024" class="usa-link" aria-describedby="cti270046-bib-0024">
<sup>24</sup>
</a>, <a href="#cti270046-bib-0025" class="usa-link" aria-describedby="cti270046-bib-0025">
<sup>25</sup>
</a> These data indicate that CAR 4 T cells are adopting a more efficient, oxidative metabolic state, which is often associated with enhanced mitochondrial function and overall cellular fitness. Together, our data indicate a more metabolically fit phenotype of CAR 4 than of CAR 1 T cells. The link between ERK activation and mitochondrial fitness further supports the notion that CAR 4 and anti‐HER2 CAR T cells maintain a less differentiated and energetically efficient state.</p>
<p>To evaluate the therapeutic potential of FLAG‐CAR 4 T cells in combination with a tumor‐targeting FLAG‐tagged reagent, we engineered a recombinant protein consisting of an anti‐HER2 scFv fused to a FLAG tag as the core targeting element (Figure <a href="#cti270046-fig-0007" class="usa-link">7a</a>). The construct also includes additional components, such as an Fc region and flexible linkers, to enhance structural flexibility, stability and serum half‐life. This molecule is hereafter referred to as H‐Flag (HER2‐scFv‐FLAG). H‐FLAG enabled robust and specific activation of FLAG‐CAR 4 T cells against HER2<sup>+</sup> tumor cells, resulting in potent cytotoxicity (Figure <a href="#cti270046-fig-0007" class="usa-link">7b</a>) and IFN‐γ secretion (Figure <a href="#cti270046-fig-0007" class="usa-link">7c</a>), only when both the HER2‐scFv‐FLAG and tumor antigen were present. Furthermore, in the orthotopic MDA‐MB‐468‐HER2 breast cancer model, FLAG‐CAR 4 T cells alone or the H‐FLAG alone had minimal impact on tumor growth, but their combination led to significant tumor regression (Figure <a href="#cti270046-fig-0007" class="usa-link">7d</a>), demonstrating the efficacy of this modular targeting strategy <em>in vivo</em>. No overt toxicity was observed in treated mice (Figure <a href="#cti270046-fig-0007" class="usa-link">7e</a>), supporting the safety of this approach.</p>
<figure class="fig xbox font-sm" id="cti270046-fig-0007"><h3 class="obj_head">Figure 7.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d7e/12370372/5f2abf716ec2/CTI2-14-e70046-g005.jpg" loading="lazy" id="jats-graphic-15" height="1036" width="709" alt="Figure 7"></p>
<div class="p text-right font-secondary"><a href="figure/cti270046-fig-0007/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>H‐FLAG enables tumor suppression by FLAG‐CAR 4 T cells. <strong>(a)</strong> Schematic of the H‐FLAG protein used to redirect FLAG‐CAR 4 T cells towards HER2<sup>+</sup> tumor cells (generated with Biorender). <strong>(b)</strong>
<em>In vitro</em> cytotoxicity of FLAG‐CAR 4 T cells against MDA‐MB‐468‐HER2‐luc cells in the presence or absence of H‐FLAG, measured by luciferase release. <strong>(c)</strong> IFN‐γ secretion by FLAG‐CAR 4 T cells co‐cultured with MDA‐MB‐468‐HER2 target cells, with or without H‐FLAG. <strong>(d)</strong> Tumor growth curves of NSG mice bearing orthotopic MDA‐MB‐468‐HER2 tumors treated with FLAG‐CAR 4 T cells, H‐FLAG, both or control. Tumor volume was measured over time. <strong>(e)</strong> Body weight. Experiments were performed independently at least twice with consistent results. Data are presented as mean ± SEM. CAR, chimeric antigen receptor. Statistical significance: *** <em>P</em> ≤ 0.001, **** <em>P</em> ≤ 0.0001.</p></figcaption></figure><p>Overall, our data showed that the optimised CAR 4 T cells outperform CAR 1 T cells. The CAR structure itself likely influences intracellular signalling, which in turn shapes the metabolic profile of CAR T cells, ultimately affecting their <em>in vitro</em> function and <em>in vivo</em> therapeutic performance. Furthermore, the use of an H‐FLAG protein enabled modular redirection of FLAG‐CAR T cells towards HER2<sup>+</sup> tumors, resulting in effective tumor clearance. These findings highlight the versatility and therapeutic potential of the anti‐FLAG CAR platform in enabling flexible targeting of solid tumors.</p></section><section id="cti270046-sec-0003"><h2 class="pmc_sec_title">Discussion</h2>
<p>CAR T‐cell therapy has shown remarkable success in treating haematological malignancies, but its efficacy in solid tumors remains limited because of major challenges like antigen heterogeneity and antigen loss. Unlike blood cancers, where a single antigen is typically uniformly expressed, solid tumors show high variability in antigen expression both across tumor types and within individual tumors, making target identification difficult and increasing the risk of treatment failure. Additionally, antigen loss is a significant challenge, as tumor cells can downregulate or mutate the targeted antigen to evade immune recognition, a process facilitated by genomic instability and clonal diversity. These factors contribute to treatment resistance, tumor recurrence and poor therapeutic outcomes, underscoring the need for strategies that enable flexible and broad targeting of tumor antigens.</p>
<p>To overcome these limitations, researchers have explored targeting exogenous antigens and using modular CAR systems that allow adaptable antigen recognition. One approach employs a CAR specific to fluorescein isothiocyanate (FITC), used in combination with an intratumorally injected amphiphile conjugated to FITC to treat solid tumors.<a href="#cti270046-bib-0026" class="usa-link" aria-describedby="cti270046-bib-0026">
<sup>26</sup>
</a> This enhances CAR T‐cell infiltration and promotes systemic anti‐tumor immunity, including abscopal effects and immune memory formation. Other universal CAR strategies include the SUPRA (split, universal and programmable) CAR<a href="#cti270046-bib-0027" class="usa-link" aria-describedby="cti270046-bib-0027">
<sup>27</sup>
</a> and convertible CAR.<a href="#cti270046-bib-0028" class="usa-link" aria-describedby="cti270046-bib-0028">
<sup>28</sup>
</a> These systems separate the CAR recognition from antigen specificity, using adaptor molecules to guide CAR T cells to different antigens. For instance, the SUPRA CAR uses a leucine zipper‐based adaptor system, while convertible CAR employs an inert NKG2D domain that binds to ULBP2‐based adaptors fused to tumor‐targeting antibodies. These designs enable controlled and flexible targeting of diverse antigens and allow for rapid reprogramming of CAR specificity.</p>
<p>Building on this concept, the current study developed a CAR targeting the FLAG‐tag, an exogenous peptide widely used in molecular biology. A key advantage of this platform is its compatibility with a broad range of tumor‐targeting antibodies and moieties, which can be readily adapted by appending a short FLAG‐tag. This modular approach not only offers flexibility and rapid antigen retargeting but also reduces the risk of off‐target toxicity, as the FLAG‐tag is not naturally expressed in human tissues. Although a theoretical risk of anti‐FLAG immune responses exists, our previous two clinical trials using a Lewis‐Y CAR incorporating a FLAG‐tag reported no associated toxicity or CAR T‐cell loss.<a href="#cti270046-bib-0029" class="usa-link" aria-describedby="cti270046-bib-0029">
<sup>29</sup>
</a>, <a href="#cti270046-bib-0030" class="usa-link" aria-describedby="cti270046-bib-0030">
<sup>30</sup>
</a>
</p>
<p>Our initial FLAG‐CAR design showed evidence of tonic signalling, leading to T‐cell exhaustion. To address this, several structural modifications were tested, including domain reordering, hinge shortening and substitution of costimulatory domains.<a href="#cti270046-bib-0014" class="usa-link" aria-describedby="cti270046-bib-0014">
<sup>14</sup>
</a>, <a href="#cti270046-bib-0015" class="usa-link" aria-describedby="cti270046-bib-0015">
<sup>15</sup>
</a>, <a href="#cti270046-bib-0016" class="usa-link" aria-describedby="cti270046-bib-0016">
<sup>16</sup>
</a>, <a href="#cti270046-bib-0021" class="usa-link" aria-describedby="cti270046-bib-0021">
<sup>21</sup>
</a> The optimised CAR, which is CAR 4, featured a truncated version of the hCD8α hinge and showed reduced tonic signalling, improved metabolic fitness and enhanced effector function. CAR4 successfully eliminated FLAG‐expressing breast cancer in the mouse models. Moreover, when used in combination with a FLAG‐tagged HER2‐scFv, CAR 4 induced significant regression of orthotopic HER2<sup>+</sup> tumors, highlighting the therapeutic potential of this flexible targeting strategy.</p>
<p>In summary, this study establishes the FLAG‐CAR as a flexible and modular platform for CAR T‐cell therapy. By addressing tonic signalling and improving T‐cell function, the optimised FLAG‐CAR demonstrates effective anti‐tumor activity. The combination of FLAG‐tagged tumor‐targeting moieties with FLAG‐CAR offers a potential strategy for adaptable redirection towards diverse tumor‐associated antigens.</p></section><section id="cti270046-sec-0004"><h2 class="pmc_sec_title">Methods</h2>
<section id="cti270046-sec-0005"><h3 class="pmc_sec_title">CAR T‐cell production</h3>
<p>Peripheral blood mononuclear cells were obtained from fresh buffy coats supplied by the Australian Red Cross Blood Service and isolated using a Ficoll density gradient. The PBMCs were then cultured in TexMACS medium (Miltenyi Biotec B.V. &amp; Co. KG, Bergisch Gladbach, Germany) supplemented with recombinant human IL‐7 and IL‐15 (Miltenyi Biotec B.V. &amp; Co. KG) at 12.5 ng mL<sup>−1</sup> and T‐cell TransAct (Miltenyi Biotec B.V. &amp; Co. KG) at a 1:100 dilution. After 48 h, the activated T cells were transduced with concentrated CAR lentiviral vectors and subsequently maintained in TexMACS medium containing 12.5 ng mL<sup>−1</sup> of recombinant human IL‐7 and IL‐15.</p>
<p>CAR T constructs were synthesised by Genscript Singapore and cloned to pCDH vector (Addgene, Watertown, USA). The CAR T plasmids were mixed with pMDLg/pRRE, pRSV‐Rev and pMD2.G plasmids (Addgene) and transfected into HEK 293 T cells using Lipofectamine 3000 (Thermo Fisher Scientific, Waltham, USA) according to the manufacturer's protocol. Supernatant containing the CAR lentiviral vectors was harvested, concentrated by ultracentrifugation with Optima XPN‐100 (Beckman Coulter, Brea, USA), titrated and stored at −80°C.</p></section><section id="cti270046-sec-0006"><h3 class="pmc_sec_title">Cytotoxicity assays</h3>
<p>Luciferase‐expressing target tumor cells were plated in a white 96‐well microplate (Revvity, Waltham, USA). CAR T cells were added at various E:T ratios as indicated. Controls included target cells alone and target cells treated with 10% SDS. Following an overnight incubation at 37°C, VivoGlo Luciferin (Promega, Madison, USA) was added at a final concentration of 300 μg mL<sup>−1</sup>. Luminescence was measured using BioTek Cytation 3 (Agilent Technologies, Santa Clara, USA). The percentage of luciferase reduction was calculated as follows:</p>
<table class="disp-formula p" id="cti270046-disp-0001"><tr><td class="formula"><math id="jats-math-1" display="block" overflow="linebreak"><mrow><mrow><mfenced open="(" close=")"><mrow><mtext>target cell alone luminescence</mtext><mspace width="0.37em"></mspace><mo linebreak="goodbreak">−</mo><mspace width="0.37em"></mspace><mtext>sample luminescence</mtext></mrow></mfenced><mo>/</mo><mfenced open="(" close=")"><mrow><mtext>target cell alone luminescence</mtext><mspace width="0.37em"></mspace><mo linebreak="goodbreak">−</mo><mspace width="0.37em"></mspace><mtext>target cell in</mtext><mspace width="0.25em"></mspace><mn>10</mn><mo>%</mo><mi>SDS</mi><mspace width="0.25em"></mspace><mtext>luminescence</mtext></mrow></mfenced><mo linebreak="goodbreak">×</mo><mn>100</mn><mo>%</mo><mo>.</mo></mrow></mrow></math></td></tr></table></section><section id="cti270046-sec-0007"><h3 class="pmc_sec_title">Cytokine assays</h3>
<p>Chimeric antigen receptor T cells were seeded to 96‐well flat‐bottom plates with an equal number of tumor cells in complete RPMI and incubated at 37°C overnight. Supernatant was collected, and cytokines were analysed using the AlphaLISA kits according to the manufacturer's protocol (Revvity, Waltham, USA). Plates were read on the BioTek Cytation 5 (Agilent Technologies, Santa Clara, USA).</p></section><section id="cti270046-sec-0008"><h3 class="pmc_sec_title">Flow cytometry</h3>
<p>Cell surface flow cytometric analysis was performed as previously described.<a href="#cti270046-bib-0011" class="usa-link" aria-describedby="cti270046-bib-0011">
<sup>11</sup>
</a>, <a href="#cti270046-bib-0012" class="usa-link" aria-describedby="cti270046-bib-0012">
<sup>12</sup>
</a>, <a href="#cti270046-bib-0013" class="usa-link" aria-describedby="cti270046-bib-0013">
<sup>13</sup>
</a> For intracellular staining, FLAG‐ or HER2‐CAR T cells were incubated with NALM6‐FLAG or NALM6‐HER2, respectively, at a 1:1 ratio in RPMI containing 0.1% fetal bovine serum (FBS) for 30 min in a 37°C water bath. At the end of incubation, samples were immediately fixed in 1:1 volume of BD Cytofix for 10 min at room temperature, then permeabilised in methanol for 10 min on ice. Samples were stained with anti‐ERK1/2 phospho (T202/Y204) antibody (clone 6B8B69, BioLegend, San Diego, USA) in buffer [phosphate‐buffered saline (PBS) containing 1% FBS and 0.09% sodium azide] for 1 h in the dark on ice. Samples were analysed on BD FACSCanto II, BD LSR II, BD LSRFortessa X‐20, BD FACSymphony A3 or A5 (BD Bioscience, San Diego, USA). Data are analysed and plotted using FlowJo™ v10.10 (BD Bioscience).</p></section><section id="cti270046-sec-0009"><h3 class="pmc_sec_title">Mouse experiments and cell lines</h3>
<p>All mouse experiments were approved by the Peter MacCallum Cancer Centre Animal Experimentation Ethics Committee. NOD.Cg‐Prkdc scid Il2rg tm1Wjl/SzJ mice (NSG) were bred at the Peter MacCallum Cancer Centre (Melbourne, Australia), and mice used for experiments were between 6 and 10 weeks of age. Experiments were conducted using a mixed cohort of male and female mice based on availability.</p>
<p>In the xenograft models, 1 × 10<sup>6</sup> MDA‐MB‐468‐FLAG cells in 20 μL PBS were injected into the left fourth mammary glands. Tumor areas were measured with a calliper twice per week and calculated as length × width. In the tumor growth and survival study, mice received 0.5 Gy total body irradiation 15 days following tumor injection and on the same day, 2 × 10<sup>6</sup> CAR T cells were injected intravenously in 200 μL PBS. In the mechanistic study, mice received 0.5 Gy total body irradiation 28 days after tumor injection, followed by intravenous injection of 5 × 10<sup>6</sup> CAR T cells in 200 μL PBS. Mice were harvested 7 days after CAR T‐cell treatment. Tumors were enzymatically digested at 37°C for 20 min with 1 mg mL<sup>−1</sup> Collagenase IV (Worthington Biochemical, Lakewood, USA), 100 μg mL<sup>−1</sup> Hyaluronidase and 75 μg mL<sup>−1</sup> DNase I (Sigma‐Aldrich, St. Louis, USA) in RPMI‐1640 medium before mechanical dissociation through a 70‐μm cell strainer. Spleens were mechanically dissociated through a 70‐μm cell strainer before red blood cell lysis. Cell suspensions were used for surface staining and analysed by flow cytometry as described above.</p>
<p>To assess the <em>in vivo</em> efficacy of the FLAG‐CAR 4 T cells in combination with the H‐FLAG protein (synthesised by GenScript, Nanjing, China), NSG mice (6–8 weeks of age) were orthotopically injected with 1 × 10<sup>6</sup> MDA‐MB‐468‐HER2 tumor cells into the fourth mammary fat pad. Thirteen days after the tumor injection, mice were randomly assigned into four treatment groups: (1) untreated control, (2) FLAG‐CAR 4 T cells alone, (3) H‐FLAG alone and (4) FLAG‐CAR 4 T cells plus H‐FLAG. Mice received a single intravenous injection of 5 × 10<sup>6</sup> FLAG‐CAR4 T cells, with or without co‐administration of 200 μg H‐FLAG on treatment days 0, 7 and 18 for a total of 3 doses. Tumor area and body weight were monitored twice per week using digital callipers and a standard formula (length × width). Mice were euthanised when tumors exceeded ethical limits or at the study endpoint.</p>
<p>All cell lines were originally purchased from ATCC and have been authenticated in‐house. Mycoplasma testing is conducted regularly, and only mycoplasma‐negative cell lines are used in our studies. Cancer cells were transduced to express HER2, FLAG or other antigens, such as luciferase, as previously described.<a href="#cti270046-bib-0011" class="usa-link" aria-describedby="cti270046-bib-0011">
<sup>11</sup>
</a>, <a href="#cti270046-bib-0012" class="usa-link" aria-describedby="cti270046-bib-0012">
<sup>12</sup>
</a>, <a href="#cti270046-bib-0013" class="usa-link" aria-describedby="cti270046-bib-0013">
<sup>13</sup>
</a>
</p></section><section id="cti270046-sec-0010"><h3 class="pmc_sec_title">Confocal microscopy</h3>
<p>Live GFP<sup>+</sup> CAR‐T cells were incubated with anti‐MYC‐AF647 (clone 9B11; Cell Signaling Technology, Danvers, USA) and anti‐CD3‐PE (clone SK7; BioLegend, San Diego, USA) antibodies for 30 min at room temperature and imaged using a Lattice Lightsheet microscope (Carl Zeiss AG; Oberkochen, Germany). Fluorescence signals were split using a 640‐nm long‐pass dichroic mirror and filtered with a 495–550‐nm bandpass for PE/GFP and a 570–620‐nm bandpass for AF647. Five images for each group were acquired. The membrane areas expressing CAR (MYC‐AF647<sup>+</sup>) were quantified using Imaris software (v10.1; Oxford Instruments, Abingdon, England). Images were pre‐processed to subtract background, and masks were generated for each channel using identical thresholding and voxel minimum parameters across all samples to ensure consistency. Cell surfaces were segmented based on cytoplasmic GFP, and MYC‐AF647 signal was confined to these segmented surfaces. Intensity measurements and spatial distribution analyses were performed using the Statistics and Spots tools, with voxel size calibrated to acquisition settings.</p></section><section id="cti270046-sec-0011"><h3 class="pmc_sec_title">Seahorse assay</h3>
<p>4 × 10<sup>5</sup>/well of CAR T cells were seeded to XFe96 cell culture microplates pre‐coated with CellTak (Corning, New York, USA) in XF base media containing 11 mM glucose, 2 mM L‐glutamine and 1 mM sodium pyruvate. The OCR and ECAR were measured by using the Seahorse XF Pro analyser (Agilent Technologies, Santa Clara, USA) at baseline and after sequential injection of oligomycin (1 μM; Merck Life Science, Bayswater, Australia), FCCP (1.5 μM; Merck Life Science), rotenone (100 nM; Merck Life Science) and antimycin A (1 μM; Merck Life Science).</p></section><section id="cti270046-sec-0012"><h3 class="pmc_sec_title">Graphical presentation and statistical analysis</h3>
<p>Data were analysed and graphed using GraphPad Prism 10 (GraphPad Software, La Jolla, USA) and Microsoft Excel (Microsoft Corporation, Albuquerque, USA). One‐way ANOVA and Tukey's multiple comparisons test or Dunnett's multiple comparisons test were used to compare groups of data. Student's <em>t</em>‐test was employed to compare two groups of data. Mouse survival was compared using the Mantel‐Cox test. Significant differences between comparisons were indicated by <em>P</em>‐values (* ≤ 0.05, ** ≤ 0.01, *** ≤ 0.001, **** ≤ 0.0001), not significant (ns).</p></section></section><section id="cti270046-sec-0017"><h2 class="pmc_sec_title">Author contributions</h2>
<p>
<strong>Xiaomeng Zhang:</strong> Investigation; methodology; software; data curation; validation; visualization; writing – original draft; writing – review and editing; formal analysis. <strong>Rachel Xu:</strong> Methodology; data curation; investigation; validation; formal analysis; visualization; writing – review and editing. <strong>Dmitry Zorin:</strong> Writing – review and editing; methodology; formal analysis; validation; investigation; data curation. <strong>Evan G Pappas:</strong> Methodology; validation; investigation; visualization; formal analysis; data curation; writing – review and editing. <strong>Jiawei Tang:</strong> Writing – review and editing; methodology; investigation; validation; visualization; formal analysis; data curation. <strong>Yuchen Bai:</strong> Methodology; validation; investigation; visualization; software; formal analysis; data curation; writing – review and editing. <strong>Vicky M Qin:</strong> Methodology; software; data curation; investigation; validation; formal analysis; visualization; writing – review and editing. <strong>Bianca von Scheidt:</strong> Methodology; data curation; investigation; validation; formal analysis; supervision; project administration; visualization; writing – review and editing. <strong>Ruihong Huang:</strong> Methodology; data curation; software; investigation; validation; visualization; writing – review and editing. <strong>Weronika Kulakowska:</strong> Writing – review and editing; methodology; investigation; validation. <strong>Charbel Darido:</strong> Writing – review and editing; supervision; conceptualization. <strong>Phillip K Darcy:</strong> Writing – review and editing; funding acquisition; project administration; resources; supervision; conceptualization. <strong>Michael H Kershaw:</strong> Writing – review and editing; funding acquisition; project administration; resources; supervision; formal analysis; methodology; conceptualization. <strong>Clare Y Slaney:</strong> Conceptualization; investigation; funding acquisition; writing – original draft; writing – review and editing; visualization; validation; methodology; software; formal analysis; project administration; resources; supervision; data curation.</p></section><section id="cti270046-sec-0014"><h2 class="pmc_sec_title">Conflict of interest</h2>
<p>The authors declare no conflict of interest.</p></section><section id="sec19"><h2 class="pmc_sec_title">Supporting information</h2>
<section class="sm xbox font-sm" id="cti270046-supitem-0001"><div class="caption p">
<p>
Supplementary figure 1
</p>
<p>
Supplementary figure 2
</p>
<p>
Supplementary figure 3
</p>
<p>
Supplementary figure 4
</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12370372/bin/CTI2-14-e70046-s001.pdf" data-ga-action="click_feat_suppl" class="usa-link">CTI2-14-e70046-s001.pdf</a><sup> (335.1KB, pdf) </sup>
</div></div></section></section><section id="cti270046-sec-0013" class="ack"><h2 class="pmc_sec_title">Acknowledgments</h2>
<p>This work was supported by grants from the CASS Foundation, the National Health and Medical Research Council (NHMRC), the National Breast Cancer Foundation (NBCF) of Australia, mRNA Victoria Research Programs, and funding from <em>Currus Biologics</em>. CYS and PKD were supported by NHMRC Investigator Grants and a Victoria Cancer Agency Mid‐Career Fellowship. YB received support from a Cancer Council Victoria (CCV) Postdoctoral Fellowship. RX was funded by a Peter Mac Foundation PhD Scholarship, EGP by a Research Training Program (RTP) PhD Scholarship and RH by a Li Ka Shing Foundation Clinical Research Training Program. The authors acknowledge the contributions of the consumer representatives, Drs Leonie Young, Pamela Williams and the NBCF Circle of Giving. We thank the Peter MacCallum Cancer Centre Research Flow Core (RRID:SCR_025550), Centre for Advanced Histology and Microscopy (RRID:SCR_025432), Victorian Centre for Functional Genomics (RRID:SCR_025582) and Cancer Research Animal Core for their respective contributions to this study. The authors acknowledge the use of ChatGPT for editorial support in improving the clarity and readability of the manuscript. Open access publishing facilitated by The University of Melbourne, as part of the Wiley ‐ The University of Melbourne agreement via the Council of Australian University Librarians.</p></section><section id="cti270046-sec-0016"><h2 class="pmc_sec_title">Data availability statement</h2>
<p>The data supporting the findings of this study are available from the corresponding author upon reasonable request.</p></section><section id="cti270046-bibl-0001" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="cti270046-bibl-0001_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="cti270046-bib-0001">
<span class="label">1.</span><cite>
Chan JD, Lai J, Slaney CY, Kallies A, Beavis PA, Darcy PK. Cellular networks controlling T cell persistence in adoptive cell therapy. Nat Rev Immunol
2021; 21: 769–784.
</cite> [<a href="https://doi.org/10.1038/s41577-021-00539-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33879873/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Rev%20Immunol&amp;title=Cellular%20networks%20controlling%20T%E2%80%89cell%20persistence%20in%20adoptive%20cell%20therapy&amp;author=JD%20Chan&amp;author=J%20Lai&amp;author=CY%20Slaney&amp;author=A%20Kallies&amp;author=PA%20Beavis&amp;volume=21&amp;publication_year=2021&amp;pages=769-784&amp;pmid=33879873&amp;doi=10.1038/s41577-021-00539-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cti270046-bib-0002">
<span class="label">2.</span><cite>
Slaney CY, Wang P, Darcy PK, Kershaw MH. CARs versus BiTEs: A comparison between T cell‐redirection strategies for cancer treatment. Cancer Discov
2018; 8: 924–934.
</cite> [<a href="https://doi.org/10.1158/2159-8290.CD-18-0297" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30012854/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Discov&amp;title=CARs%20versus%20BiTEs:%20A%20comparison%20between%20T%20cell%E2%80%90redirection%20strategies%20for%20cancer%20treatment&amp;author=CY%20Slaney&amp;author=P%20Wang&amp;author=PK%20Darcy&amp;author=MH%20Kershaw&amp;volume=8&amp;publication_year=2018&amp;pages=924-934&amp;pmid=30012854&amp;doi=10.1158/2159-8290.CD-18-0297&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cti270046-bib-0003">
<span class="label">3.</span><cite>
Mougiakakos D, Kronke G, Volkl S
<em>et al</em>. CD19‐targeted CAR T cells in refractory systemic lupus erythematosus. N Engl J Med
2021; 385: 567–569.
</cite> [<a href="https://doi.org/10.1056/NEJMc2107725" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34347960/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&amp;title=CD19%E2%80%90targeted%20CAR%20T%E2%80%89cells%20in%20refractory%20systemic%20lupus%20erythematosus&amp;author=D%20Mougiakakos&amp;author=G%20Kronke&amp;author=S%20Volkl&amp;volume=385&amp;publication_year=2021&amp;pages=567-569&amp;pmid=34347960&amp;doi=10.1056/NEJMc2107725&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cti270046-bib-0004">
<span class="label">4.</span><cite>
Morte‐Romea E, Pesini C, Pellejero‐Sagastizabal G
<em>et al</em>. CAR immunotherapy for the treatment of infectious diseases: A systematic review. Front Immunol
2024; 15: 1289303.
</cite> [<a href="https://doi.org/10.3389/fimmu.2024.1289303" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10861799/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38352878/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Immunol&amp;title=CAR%20immunotherapy%20for%20the%20treatment%20of%20infectious%20diseases:%20A%20systematic%20review&amp;author=E%20Morte%E2%80%90Romea&amp;author=C%20Pesini&amp;author=G%20Pellejero%E2%80%90Sagastizabal&amp;volume=15&amp;publication_year=2024&amp;pages=1289303&amp;pmid=38352878&amp;doi=10.3389/fimmu.2024.1289303&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cti270046-bib-0005">
<span class="label">5.</span><cite>
Rurik JG, Tombacz I, Yadegari A
<em>et al</em>. CAR T cells produced in vivo to treat cardiac injury. Science
2022; 375: 91–96.
</cite> [<a href="https://doi.org/10.1126/science.abm0594" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9983611/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34990237/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=CAR%20T%E2%80%89cells%20produced%20in%20vivo%20to%20treat%20cardiac%20injury&amp;author=JG%20Rurik&amp;author=I%20Tombacz&amp;author=A%20Yadegari&amp;volume=375&amp;publication_year=2022&amp;pages=91-96&amp;pmid=34990237&amp;doi=10.1126/science.abm0594&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cti270046-bib-0006">
<span class="label">6.</span><cite>
Cappell KM, Kochenderfer JN. Long‐term outcomes following CAR T cell therapy: What we know so far. Nat Rev Clin Oncol
2023; 20: 359–371.
</cite> [<a href="https://doi.org/10.1038/s41571-023-00754-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10100620/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37055515/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Rev%20Clin%20Oncol&amp;title=Long%E2%80%90term%20outcomes%20following%20CAR%20T%E2%80%89cell%20therapy:%20What%20we%20know%20so%20far&amp;author=KM%20Cappell&amp;author=JN%20Kochenderfer&amp;volume=20&amp;publication_year=2023&amp;pages=359-371&amp;pmid=37055515&amp;doi=10.1038/s41571-023-00754-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cti270046-bib-0007">
<span class="label">7.</span><cite>
Brown CE, Alizadeh D, Starr R
<em>et al</em>. Regression of glioblastoma after chimeric antigen receptor T‐cell therapy. N Engl J Med
2016; 375: 2561–2569.
</cite> [<a href="https://doi.org/10.1056/NEJMoa1610497" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5390684/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28029927/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&amp;title=Regression%20of%20glioblastoma%20after%20chimeric%20antigen%20receptor%20T%E2%80%90cell%20therapy&amp;author=CE%20Brown&amp;author=D%20Alizadeh&amp;author=R%20Starr&amp;volume=375&amp;publication_year=2016&amp;pages=2561-2569&amp;pmid=28029927&amp;doi=10.1056/NEJMoa1610497&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cti270046-bib-0008">
<span class="label">8.</span><cite>
Kershaw MK, Slaney CY, von Scheidt B. Bispecific polypeptides for engagement of CAR expressing immune cells with antigen presenting cells and uses thereof. US Patent
2024: 11866504.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=US%20Patent&amp;title=Bispecific%20polypeptides%20for%20engagement%20of%20CAR%20expressing%20immune%20cells%20with%20antigen%20presenting%20cells%20and%20uses%20thereof&amp;author=MK%20Kershaw&amp;author=CY%20Slaney&amp;author=B%20von%20Scheidt&amp;publication_year=2024&amp;pages=11866504&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cti270046-bib-0009">
<span class="label">9.</span><cite>
Ahmed N, Brawley V, Hegde M
<em>et al</em>. HER2‐specific chimeric antigen receptor‐modified virus‐specific T cells for progressive glioblastoma: A phase 1 dose‐escalation trial. JAMA Oncol
2017; 3: 1094–1101.
</cite> [<a href="https://doi.org/10.1001/jamaoncol.2017.0184" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5747970/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28426845/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA%20Oncol&amp;title=HER2%E2%80%90specific%20chimeric%20antigen%20receptor%E2%80%90modified%20virus%E2%80%90specific%20T%E2%80%89cells%20for%20progressive%20glioblastoma:%20A%20phase%201%20dose%E2%80%90escalation%20trial&amp;author=N%20Ahmed&amp;author=V%20Brawley&amp;author=M%20Hegde&amp;volume=3&amp;publication_year=2017&amp;pages=1094-1101&amp;pmid=28426845&amp;doi=10.1001/jamaoncol.2017.0184&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cti270046-bib-0010">
<span class="label">10.</span><cite>
Ahmed N, Brawley VS, Hegde M
<em>et al</em>. Human epidermal growth factor receptor 2 (HER2)‐specific chimeric antigen receptor‐modified T cells for the immunotherapy of HER2‐positive sarcoma. J Clin Oncol
2015; 33: 1688–1696.
</cite> [<a href="https://doi.org/10.1200/JCO.2014.58.0225" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4429176/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25800760/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Oncol&amp;title=Human%20epidermal%20growth%20factor%20receptor%202%20(HER2)%E2%80%90specific%20chimeric%20antigen%20receptor%E2%80%90modified%20T%E2%80%89cells%20for%20the%20immunotherapy%20of%20HER2%E2%80%90positive%20sarcoma&amp;author=N%20Ahmed&amp;author=VS%20Brawley&amp;author=M%20Hegde&amp;volume=33&amp;publication_year=2015&amp;pages=1688-1696&amp;pmid=25800760&amp;doi=10.1200/JCO.2014.58.0225&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cti270046-bib-0011">
<span class="label">11.</span><cite>
Ali AI, Wang M, von Scheidt B
<em>et al</em>. A histone deacetylase inhibitor, panobinostat, enhances chimeric antigen receptor T‐cell antitumor effect against pancreatic cancer. Clin Cancer Res
2021; 27: 6222–6234.
</cite> [<a href="https://doi.org/10.1158/1078-0432.CCR-21-1141" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34475103/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Cancer%20Res&amp;title=A%20histone%20deacetylase%20inhibitor,%20panobinostat,%20enhances%20chimeric%C2%A0antigen%20receptor%20T%E2%80%90cell%20antitumor%20effect%20against%20pancreatic%20cancer&amp;author=AI%20Ali&amp;author=M%20Wang&amp;author=B%20von%20Scheidt&amp;volume=27&amp;publication_year=2021&amp;pages=6222-6234&amp;pmid=34475103&amp;doi=10.1158/1078-0432.CCR-21-1141&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cti270046-bib-0012">
<span class="label">12.</span><cite>
von Scheidt B, Wang M, Oliver AJ
<em>et al</em>. Enterotoxins can support CAR T cells against solid tumors. Proc Natl Acad Sci USA
2019; 116: 25229–25235.
</cite> [<a href="https://doi.org/10.1073/pnas.1904618116" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6911243/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31767744/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proc%20Natl%20Acad%20Sci%20USA&amp;title=Enterotoxins%20can%20support%20CAR%20T%E2%80%89cells%20against%20solid%20tumors&amp;author=B%20von%20Scheidt&amp;author=M%20Wang&amp;author=AJ%20Oliver&amp;volume=116&amp;publication_year=2019&amp;pages=25229-25235&amp;pmid=31767744&amp;doi=10.1073/pnas.1904618116&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cti270046-bib-0013">
<span class="label">13.</span><cite>
Chan JD, von Scheidt B, Zeng B
<em>et al</em>. Enhancing chimeric antigen receptor T‐cell immunotherapy against cancer using a nanoemulsion‐based vaccine targeting cross‐presenting dendritic cells. Clin Transl Immunol
2020; 9: e1157.</cite> [<a href="https://doi.org/10.1002/cti2.1157" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7374388/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32704371/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Transl%20Immunol&amp;title=Enhancing%20chimeric%20antigen%20receptor%20T%E2%80%90cell%20immunotherapy%20against%20cancer%20using%20a%20nanoemulsion%E2%80%90based%20vaccine%20targeting%20cross%E2%80%90presenting%20dendritic%20cells&amp;author=JD%20Chan&amp;author=B%20von%20Scheidt&amp;author=B%20Zeng&amp;volume=9&amp;publication_year=2020&amp;pages=e1157&amp;pmid=32704371&amp;doi=10.1002/cti2.1157&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cti270046-bib-0014">
<span class="label">14.</span><cite>
Chen J, Qiu S, Li W
<em>et al</em>. Tuning charge density of chimeric antigen receptor optimizes tonic signaling and CAR‐T cell fitness. Cell Res
2023; 33: 341–354.
</cite> [<a href="https://doi.org/10.1038/s41422-023-00789-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10156745/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36882513/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Res&amp;title=Tuning%20charge%20density%20of%20chimeric%20antigen%20receptor%20optimizes%20tonic%20signaling%20and%20CAR%E2%80%90T%20cell%20fitness&amp;author=J%20Chen&amp;author=S%20Qiu&amp;author=W%20Li&amp;volume=33&amp;publication_year=2023&amp;pages=341-354&amp;pmid=36882513&amp;doi=10.1038/s41422-023-00789-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cti270046-bib-0015">
<span class="label">15.</span><cite>
Long AH, Haso WM, Shern JF
<em>et al</em>. 4‐1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors. Nat Med
2015; 21: 581–590.
</cite> [<a href="https://doi.org/10.1038/nm.3838" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4458184/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25939063/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Med&amp;title=4%E2%80%901BB%20costimulation%20ameliorates%20T%E2%80%89cell%20exhaustion%20induced%20by%20tonic%20signaling%20of%20chimeric%20antigen%20receptors&amp;author=AH%20Long&amp;author=WM%20Haso&amp;author=JF%20Shern&amp;volume=21&amp;publication_year=2015&amp;pages=581-590&amp;pmid=25939063&amp;doi=10.1038/nm.3838&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cti270046-bib-0016">
<span class="label">16.</span><cite>
Qiu S, Chen J, Wu T
<em>et al</em>. CAR‐toner: An AI‐driven approach for CAR tonic signaling prediction and optimization. Cell Res
2024; 34: 386–388.
</cite> [<a href="https://doi.org/10.1038/s41422-024-00936-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11061301/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38351128/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Res&amp;title=CAR%E2%80%90toner:%20An%20AI%E2%80%90driven%20approach%20for%20CAR%20tonic%20signaling%20prediction%20and%20optimization&amp;author=S%20Qiu&amp;author=J%20Chen&amp;author=T%20Wu&amp;volume=34&amp;publication_year=2024&amp;pages=386-388&amp;pmid=38351128&amp;doi=10.1038/s41422-024-00936-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cti270046-bib-0017">
<span class="label">17.</span><cite>
Weber EW, Parker KR, Sotillo E
<em>et al</em>. Transient rest restores functionality in exhausted CAR‐T cells through epigenetic remodeling. Science
2021; 372: eaba1786.
</cite> [<a href="https://doi.org/10.1126/science.aba1786" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8049103/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33795428/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Transient%20rest%20restores%20functionality%20in%20exhausted%20CAR%E2%80%90T%20cells%20through%20epigenetic%20remodeling&amp;author=EW%20Weber&amp;author=KR%20Parker&amp;author=E%20Sotillo&amp;volume=372&amp;publication_year=2021&amp;pages=eaba1786&amp;pmid=33795428&amp;doi=10.1126/science.aba1786&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cti270046-bib-0018">
<span class="label">18.</span><cite>
Mazinani M, Rahbarizadeh F. CAR‐T cell potency: From structural elements to vector backbone components. Biomark Res
2022; 10: 70.
</cite> [<a href="https://doi.org/10.1186/s40364-022-00417-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9487061/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36123710/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomark%20Res&amp;title=CAR%E2%80%90T%20cell%20potency:%20From%20structural%20elements%20to%20vector%20backbone%20components&amp;author=M%20Mazinani&amp;author=F%20Rahbarizadeh&amp;volume=10&amp;publication_year=2022&amp;pages=70&amp;pmid=36123710&amp;doi=10.1186/s40364-022-00417-w&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cti270046-bib-0019">
<span class="label">19.</span><cite>
Hudecek M, Lupo‐Stanghellini MT, Kosasih PL
<em>et al</em>. Receptor affinity and extracellular domain modifications affect tumor recognition by ROR1‐specific chimeric antigen receptor T cells. Clin Cancer Res
2013; 19: 3153–3164.
</cite> [<a href="https://doi.org/10.1158/1078-0432.CCR-13-0330" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3804130/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23620405/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Cancer%20Res&amp;title=Receptor%20affinity%20and%20extracellular%20domain%20modifications%20affect%20tumor%20recognition%20by%20ROR1%E2%80%90specific%20chimeric%20antigen%20receptor%20T%E2%80%89cells&amp;author=M%20Hudecek&amp;author=MT%20Lupo%E2%80%90Stanghellini&amp;author=PL%20Kosasih&amp;volume=19&amp;publication_year=2013&amp;pages=3153-3164&amp;pmid=23620405&amp;doi=10.1158/1078-0432.CCR-13-0330&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cti270046-bib-0020">
<span class="label">20.</span><cite>
Alabanza L, Pegues M, Geldres C
<em>et al</em>. Function of novel anti‐CD19 chimeric antigen receptors with human variable regions is affected by hinge and transmembrane domains. Mol Ther
2017; 25: 2452–2465.
</cite> [<a href="https://doi.org/10.1016/j.ymthe.2017.07.013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5675490/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28807568/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol%20Ther&amp;title=Function%20of%20novel%20anti%E2%80%90CD19%20chimeric%20antigen%20receptors%20with%20human%20variable%20regions%20is%20affected%20by%20hinge%20and%20transmembrane%20domains&amp;author=L%20Alabanza&amp;author=M%20Pegues&amp;author=C%20Geldres&amp;volume=25&amp;publication_year=2017&amp;pages=2452-2465&amp;pmid=28807568&amp;doi=10.1016/j.ymthe.2017.07.013&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cti270046-bib-0021">
<span class="label">21.</span><cite>
Tousley AM, Rotiroti MC, Labanieh L
<em>et al</em>. Co‐opting signalling molecules enables logic‐gated control of CAR T cells. Nature
2023; 615: 507–516.
</cite> [<a href="https://doi.org/10.1038/s41586-023-05778-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10564584/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36890224/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Co%E2%80%90opting%20signalling%20molecules%20enables%20logic%E2%80%90gated%20control%20of%20CAR%20T%E2%80%89cells&amp;author=AM%20Tousley&amp;author=MC%20Rotiroti&amp;author=L%20Labanieh&amp;volume=615&amp;publication_year=2023&amp;pages=507-516&amp;pmid=36890224&amp;doi=10.1038/s41586-023-05778-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cti270046-bib-0022">
<span class="label">22.</span><cite>
Feucht J, Sun J, Eyquem J
<em>et al</em>. Calibration of CAR activation potential directs alternative T cell fates and therapeutic potency. Nat Med
2019; 25: 82–88.
</cite> [<a href="https://doi.org/10.1038/s41591-018-0290-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6532069/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30559421/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Med&amp;title=Calibration%20of%20CAR%20activation%20potential%20directs%20alternative%20T%E2%80%89cell%20fates%20and%20therapeutic%20potency&amp;author=J%20Feucht&amp;author=J%20Sun&amp;author=J%20Eyquem&amp;volume=25&amp;publication_year=2019&amp;pages=82-88&amp;pmid=30559421&amp;doi=10.1038/s41591-018-0290-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cti270046-bib-0023">
<span class="label">23.</span><cite>
Tantalo DG, Oliver AJ, von Scheidt B
<em>et al</em>. Understanding T cell phenotype for the design of effective chimeric antigen receptor T cell therapies. J Immunother Cancer
2021; 9: e002555.
</cite> [<a href="https://doi.org/10.1136/jitc-2021-002555" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8154965/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34035114/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Immunother%20Cancer&amp;title=Understanding%20T%E2%80%89cell%20phenotype%20for%20the%20design%20of%20effective%20chimeric%20antigen%20receptor%20T%E2%80%89cell%20therapies&amp;author=DG%20Tantalo&amp;author=AJ%20Oliver&amp;author=B%20von%20Scheidt&amp;volume=9&amp;publication_year=2021&amp;pages=e002555&amp;pmid=34035114&amp;doi=10.1136/jitc-2021-002555&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cti270046-bib-0024">
<span class="label">24.</span><cite>
Chan JD, Scheffler CM, Munoz I
<em>et al</em>. FOXO1 enhances CAR T cell stemness, metabolic fitness and efficacy. Nature
2024; 629: 201–210.
</cite> [<a href="https://doi.org/10.1038/s41586-024-07242-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11062918/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38600376/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=FOXO1%20enhances%20CAR%20T%E2%80%89cell%20stemness,%20metabolic%20fitness%20and%20efficacy&amp;author=JD%20Chan&amp;author=CM%20Scheffler&amp;author=I%20Munoz&amp;volume=629&amp;publication_year=2024&amp;pages=201-210&amp;pmid=38600376&amp;doi=10.1038/s41586-024-07242-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cti270046-bib-0025">
<span class="label">25.</span><cite>
Geltink RIK, Kyle RL, Pearce EL. Unraveling the complex interplay between T cell metabolism and function. Annu Rev Immunol
2018; 36: 461–488.
</cite> [<a href="https://doi.org/10.1146/annurev-immunol-042617-053019" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6323527/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29677474/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Annu%20Rev%20Immunol&amp;title=Unraveling%20the%20complex%20interplay%20between%20T%E2%80%89cell%20metabolism%20and%20function&amp;author=RIK%20Geltink&amp;author=RL%20Kyle&amp;author=EL%20Pearce&amp;volume=36&amp;publication_year=2018&amp;pages=461-488&amp;pmid=29677474&amp;doi=10.1146/annurev-immunol-042617-053019&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cti270046-bib-0026">
<span class="label">26.</span><cite>
Zhang AQ, Hostetler A, Chen LE
<em>et al</em>. Universal redirection of CAR T cells against solid tumours via membrane‐inserted ligands for the CAR. Nat Biomed Eng
2023; 7: 1113–1128.
</cite> [<a href="https://doi.org/10.1038/s41551-023-01048-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10504084/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37291434/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Biomed%20Eng&amp;title=Universal%20redirection%20of%20CAR%20T%E2%80%89cells%20against%20solid%20tumours%20via%20membrane%E2%80%90inserted%20ligands%20for%20the%20CAR&amp;author=AQ%20Zhang&amp;author=A%20Hostetler&amp;author=LE%20Chen&amp;volume=7&amp;publication_year=2023&amp;pages=1113-1128&amp;pmid=37291434&amp;doi=10.1038/s41551-023-01048-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cti270046-bib-0027">
<span class="label">27.</span><cite>
Cho JH, Collins JJ, Wong WW. Universal chimeric antigen receptors for multiplexed and logical control of T cell responses. Cell
2018; 173: 1426–1438.
</cite> [<a href="https://doi.org/10.1016/j.cell.2018.03.038" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5984158/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29706540/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=Universal%20chimeric%20antigen%20receptors%20for%20multiplexed%20and%20logical%20control%20of%20T%E2%80%89cell%20responses&amp;author=JH%20Cho&amp;author=JJ%20Collins&amp;author=WW%20Wong&amp;volume=173&amp;publication_year=2018&amp;pages=1426-1438&amp;pmid=29706540&amp;doi=10.1016/j.cell.2018.03.038&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cti270046-bib-0028">
<span class="label">28.</span><cite>
Landgraf KE, Williams SR, Steiger D
<em>et al</em>. convertibleCARs: A chimeric antigen receptor system for flexible control of activity and antigen targeting. Commun Biol
2020; 3: 296.
</cite> [<a href="https://doi.org/10.1038/s42003-020-1021-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7283332/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32518350/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Commun%20Biol&amp;title=convertibleCARs:%20A%20chimeric%20antigen%20receptor%20system%20for%20flexible%20control%20of%20activity%20and%20antigen%20targeting&amp;author=KE%20Landgraf&amp;author=SR%20Williams&amp;author=D%20Steiger&amp;volume=3&amp;publication_year=2020&amp;pages=296&amp;pmid=32518350&amp;doi=10.1038/s42003-020-1021-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cti270046-bib-0029">
<span class="label">29.</span><cite>
Meyran D, Zhu JJ, Butler J
<em>et al</em>. T(STEM)‐like CAR‐T cells exhibit improved persistence and tumor control compared with conventional CAR‐T cells in preclinical models. Sci Transl Med
2023; 15: eabk1900.
</cite> [<a href="https://doi.org/10.1126/scitranslmed.abk1900" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37018415/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci%20Transl%20Med&amp;title=T(STEM)%E2%80%90like%20CAR%E2%80%90T%20cells%20exhibit%20improved%20persistence%20and%20tumor%20control%20compared%20with%20conventional%20CAR%E2%80%90T%20cells%20in%20preclinical%20models&amp;author=D%20Meyran&amp;author=JJ%20Zhu&amp;author=J%20Butler&amp;volume=15&amp;publication_year=2023&amp;pages=eabk1900&amp;pmid=37018415&amp;doi=10.1126/scitranslmed.abk1900&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cti270046-bib-0030">
<span class="label">30.</span><cite>
Ritchie DS, Neeson PJ, Khot A
<em>et al</em>. Persistence and efficacy of second generation CAR T cell against the LeY antigen in acute myeloid leukemia. Mol Ther
2013; 21: 2122–2129.
</cite> [<a href="https://doi.org/10.1038/mt.2013.154" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3831035/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23831595/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol%20Ther&amp;title=Persistence%20and%20efficacy%20of%20second%20generation%20CAR%20T%E2%80%89cell%20against%20the%20LeY%20antigen%20in%20acute%20myeloid%20leukemia&amp;author=DS%20Ritchie&amp;author=PJ%20Neeson&amp;author=A%20Khot&amp;volume=21&amp;publication_year=2013&amp;pages=2122-2129&amp;pmid=23831595&amp;doi=10.1038/mt.2013.154&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="caption p">
<p>
Supplementary figure 1
</p>
<p>
Supplementary figure 2
</p>
<p>
Supplementary figure 3
</p>
<p>
Supplementary figure 4
</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12370372/bin/CTI2-14-e70046-s001.pdf" data-ga-action="click_feat_suppl" class="usa-link">CTI2-14-e70046-s001.pdf</a><sup> (335.1KB, pdf) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>The data supporting the findings of this study are available from the corresponding author upon reasonable request.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Clinical &amp; Translational Immunology are provided here courtesy of <strong>Australasian Society of Immunology</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1002/cti2.70046"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/CTI2-14-e70046.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (2.9 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12370372/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12370372/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12370372%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12370372/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12370372/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12370372/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40851786/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12370372/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40851786/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12370372/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12370372/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="sGNUdj9GH8J8LdAMpn3b1q0ROFJehxX0vl3SibfwlpSOEs4hLr7LnTDO2w8c3W66">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
        <script type="module" crossorigin="" src="/static/assets/math-574fdcc6.js"></script>
    
    

    </body>
</html>
